Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side ...
Aug 28, 2019
2
886
Eating a plant-based diet may be an effective treatment for Crohn's disease, according to a case study published in the journal Nutrients.
Jun 22, 2019
0
17
Humans have discovered an almost infinite amount of ways to have sex —and things to have sex with. The famous sex researcher Alfred Kinsey said: "The only unnatural sex act is that which can't be performed."
Jun 21, 2019
2
0
While the measles vaccine has eliminated the virus in many high-income countries, the global burden of disease persists with an estimated 245,000 measles cases and 68,000 measles-associated deaths worldwide in 2016. India ...
Jun 20, 2019
0
0
The medical use of cannabis is growing. Medical marijuana may improve symptoms including pain and anorexia. While it may improve nausea and vomiting, it can rarely cause a hyperemesis syndrome with chronic use. Because this ...
Jun 10, 2019
0
0
The standards and expectations to which men and woman generally conform impact health across life stages, health sectors and world regions, finds a new study from the Brown School at Washington University in St. Louis.
Jun 10, 2019
0
25
Some 500,000 Australians live with the daily burden of a wound that does not heal, but a risk assessment tool that provides an 'early warning' of which venous leg ulcer wounds need specialised treatment has been developed ...
Jun 6, 2019
1
0
New research by King's College London, published today in the American Journal of Gastroenterology, finds that the public's perception of constipation differs drastically from that of doctors' and from the formal diagnosis ...
Jun 6, 2019
0
6
Polydactyly is the extraordinary condition of someone being born with more than five fingers or toes. In a case study published in Nature Communications, researchers from the University of Freiburg, Imperial College London, ...
Jun 3, 2019
0
287
Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published ...
May 21, 2019
0
7
